ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Tevogen Bio Holdings Inc

Tevogen Bio Holdings Inc (TVGN)

1.03
-0.02
(-1.90%)
Cerrado 27 Diciembre 3:00PM
1.02
-0.01
( -0.97% )
Pre Mercado: 8:13AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
1.02
Postura de Compra
1.01
Postura de Venta
1.03
Volume Operado de la Acción
59,563
0.00 Rango del Día 0.00
0.2556 Rango de 52 semanas 21.09
Capitalización de Mercado [m]
Precio Anterior
1.03
Precio de Apertura
-
Última hora de negociación
08:15:11
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
17,929,389
Acciones en circulación
175,051,247
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2,575.00
Beneficio por acción (BPA)
-0
turnover
-
Beneficio neto
-67k

Acerca de Tevogen Bio Holdings Inc

Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.

Sector
Biological Pds,ex Diagnstics
Industria
Blank Checks
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
2024
Tevogen Bio Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TVGN. The last closing price for Tevogen Bio was US$1.03. Over the last year, Tevogen Bio shares have traded in a share price range of US$ 0.2556 to US$ 21.09.

Tevogen Bio currently has 175,051,247 shares in issue. The market capitalisation of Tevogen Bio is US$180.30 million. Tevogen Bio has a price to earnings ratio (PE ratio) of -2575.00.

TVGN Últimas noticias

Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference

The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies...

Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame

WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi, CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech...

Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy

WARREN, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model

Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023...

UPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials

Key Takeaways: Since its founding in 2020, Tevogen Bio has developed a significant asset portfolio, and kept expenditures under $40 million, a fraction of the industry norm.Tevogen’s success...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.04014.092254311660.97991.270.9519905631.05046437CS
4-0.3-22.72727272731.321.320.856515062211.04956241CS
120.741265.5913978490.2793.090.2556179293891.55897897CS
260.2837.83783783780.743.090.255684479631.54497783CS
52-3.08-75.12195121954.121.090.255652201101.55755456CS
156-3.08-75.12195121954.121.090.255652201101.55755456CS
260-3.08-75.12195121954.121.090.255652201101.55755456CS

TVGN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Tevogen Bio?
El precio actual de las acciones de Tevogen Bio es US$ 1.02
¿Cuántas acciones de Tevogen Bio están en circulación?
Tevogen Bio tiene 175,051,247 acciones en circulación
¿Cuál es la capitalización de mercado de Tevogen Bio?
La capitalización de mercado de Tevogen Bio es USD 180.3M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Tevogen Bio?
Tevogen Bio ha negociado en un rango de US$ 0.2556 a US$ 21.09 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Tevogen Bio?
El ratio precio/beneficio de Tevogen Bio es -2.58k
¿Cuál es la moneda de reporte de Tevogen Bio?
Tevogen Bio presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Tevogen Bio?
El último beneficio anual de Tevogen Bio es USD -67k
¿Cuál es la dirección registrada de Tevogen Bio?
La dirección registrada de Tevogen Bio es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Tevogen Bio?
La dirección del sitio web de Tevogen Bio es www.tevogen.com/
¿En qué sector industrial opera Tevogen Bio?
Tevogen Bio opera en el sector BLANK CHECKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AALAmerican Airlines Group Inc
US$ 17.34
(0.00%)
271.28k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.73
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.21
(0.00%)
3.82k
AACGATA Creativity Global
US$ 0.762551
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.34
(0.00%)
271.28k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.73
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.21
(0.00%)
3.82k
AACGATA Creativity Global
US$ 0.762551
(0.00%)
0
NXUNXU Inc
US$ 0.2434
(0.00%)
122.23M
WATTEnergous Corporation
US$ 0.4112
(0.00%)
65.17M
VINCVincerx Inc
US$ 0.194
(0.00%)
27.72M
INTZIntrusion Inc
US$ 2.16
(0.00%)
26.19M
SMXSMX Security Matters Public Company
US$ 0.3536
(0.00%)
25.31M

TVGN Discussion

Ver más
glenn1919 glenn1919 6 días hace
TVGN...........................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
Joe DiMaggio Joe DiMaggio 1 mes hace
Buyback is on
👍️0
oleskool oleskool 1 mes hace
can this hit 2$ , gut says not gonna happen
👍️0
tw0122 tw0122 1 mes hace
See $4 zone ($4.20$4.54) as resistance now with the news eliminating debt and liabilities. Moves up slowly..
Tevogen reiterated its confidence in its financial stability, confirming sufficient available capital to fund operations for at least the next 33 months, supported by a loan agreement, which Tevogen entered into in June. Additionally, Tevogen eliminated almost all of its liabilities which were $99.9 million as reported at December 31, 2023 and now are $10.5 million as reported at September 30, 2024.





Tevogen’s internally developed intellectual property and product assets, valued internally at $10 billion+ using discounted cash flow models, are not reflected on the balance sheet. Due to US GAAP accounting rules, the company was unable to report the fair market value of its assets, including proprietary immunotherapy technologies and cutting-edge artificial intelligence platforms. The company believes that the inclusion of Tevogen’s IP assets on its balance sheet would significantly enhance its enterprise value



Commenting on the company’s performance and unique ownership structure, Dr. Saadi concluded, “Tevogen’s leadership stands apart in the biotech sector, with approximately 78% of equity retained by our officers, an extraordinary figure compared to the industry average of just 4%. In addition to our officers, our key employees have also been granted substantial restricted stock units in the company, reflecting our belief that our employees should also be owners of our success.”





👍 1 🚀 1
glenn1919 glenn1919 1 mes hace
TVGN.........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍 1 🔥 1
glenn1919 glenn1919 2 meses hace
TVGN..........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
BurgerKing82 BurgerKing82 2 meses hace
Looks interesting
👍️0
glenn1919 glenn1919 2 meses hace
TVGN..................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️ 1
tw0122 tw0122 2 meses hace
$1.32 + 10% .. WARREN, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, nears finalization of agreement with CD8 Technology for a turn-key facility intended to support both pre-clinical research and GMP manufacturing capabilities, staffed by Tevogen.
👍️ 1
OffTheGrid OffTheGrid 2 meses hace
Adding 
👍️0
HoldEm777 HoldEm777 2 meses hace
https://www.stocktitan.net/news/TVGNW/tevogen-bio-expands-on-microsoft-partnership-to-integrate-machine-zepglnzxz4n7.html
👍️0
BardRaider17 BardRaider17 2 meses hace
Yes sir
👍️0
getitrit getitrit 2 meses hace
Is it true they are partners with Microsoft?
👍️0
BardRaider17 BardRaider17 2 meses hace
I think I messed up. I'm sitting on 555 @ average 2.58 I really did not want to be stuck in that overnight. Thoughts?
👍️0
tw0122 tw0122 2 meses hace
Flip out some $2.60s 
👍️ 1
tw0122 tw0122 2 meses hace
Back in $2.20s for a flip maybe quick hopefully longer 
👍️ 1
tw0122 tw0122 2 meses hace
Not much pumped some premarket so always careful have to see if $2.29- $2.47 zone holds afee profit taking then will add some perhaps 
👍️0
BardRaider17 BardRaider17 2 meses hace
Can you explain what that means for me? Im new TY
👍️0
tw0122 tw0122 2 meses hace
TVGN 3.20 trading float about 21m about 15m traded so far 
👍️0
tw0122 tw0122 2 meses hace
TVGN $4s coming will trade whole float by 930am
👍️0
tw0122 tw0122 2 meses hace
Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This WeekOctober 22 2024 - 2:30PM


Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to provide further updates on the previously announced revenue forecast for Tevogen Oncology and Tevogen Specialty Care therapeutic areas by the end of this week. The revenue forecast for the two therapeutic areas is approximately $1 billion each in their respective launch years. The 5-year combined estimate for the two therapeutic areas is between $28 billion and $36 billion.Tevogen Bio also plans to update shareholders on Tevogen AI, its proprietary artificial intelligence effort, designed to advance a mission to lower the total cost of drug development, expedite drug discovery, and deliver life-changing therapies to large patient populations. In addition, Tevogen Bio will provide an update on clinical and commercial manufacturing.
👍️0
tw0122 tw0122 2 meses hace
TVGN 3.75 -3.88 zone up there and then $4.27 on high side in the 2.62-3.40 zone for now
👍️0
glenn1919 glenn1919 2 meses hace
tvgn............................https://stockcharts.com/h-sc/ui?s=tvgn&p=W&b=5&g=0&id=p86431144783
👍️0
dinogreeves dinogreeves 2 meses hace
Actually buying more tomorrow, price targets changed 16-18 dollars by year end.
👍️0
eur06 eur06 2 meses hace
In less than 2 years CVNA went absolutely nuts wow!!!
TVGN
👍️0
da_stock_analyst da_stock_analyst 2 meses hace
#TVGN 🔥 70% short interest & $TVGN squeezing! watch this week!
👍️0
frans frans 2 meses hace
thanks
👍️0
dinogreeves dinogreeves 2 meses hace
SAVE could do similar pattern as CVNA did.
👍️0
dinogreeves dinogreeves 2 meses hace
For me personally not going to wait 10-12. I will sell at $6.00
👍️0
frans frans 2 meses hace
SAVE - when to 10 - 12 $ and who is selling all those shares?
👍️0
dinogreeves dinogreeves 2 meses hace
SAVE will run big 10-12 dollars
👍️0
eur06 eur06 2 meses hace
Wow uavs!!!!
save still ok ?
TVGN
👍️0
dinogreeves dinogreeves 2 meses hace
It was a great setup, I was looking for the Microsoft deal to come through and it did. Made my move on SAVE and UAVS.
👍️0
dinogreeves dinogreeves 2 meses hace
No loaded 4000 shares this morning, it should run to 7-8 dollars but it will get to 10-12 dollar range. Float is next to nothing. They have contracts with the French Army and the United Nations. Severly undervalued.
👍️0
eur06 eur06 2 meses hace
Wow that chart looks hot hot hot..lol
Just got some…waiting for updates?
TVGN
👍️0
tw0122 tw0122 2 meses hace
TVGN 2.90 time to flip this champ again. Happy trading 
👍️0
dinogreeves dinogreeves 2 meses hace
Buy UAVS too.
👍️0
eur06 eur06 2 meses hace
Great call dino…we’re making $$$ so far!!!!
OSS
👍️0
tw0122 tw0122 2 meses hace
MSFT deal $2.50 +50%
👍️0
TimeFades TimeFades 2 meses hace
Moon soon. A lot of headwinds
👍️0
JUST 10-11-12 JUST 10-11-12 2 meses hace
This should go much higher than five: "..... Dr. Saadi added, "I was pleased that Tevogen was able to provide updates on the Company, including our pipeline, our $1 billion launch year oncology guidance, and I expect to share more details on further progress in the coming days."....."
👍️0
JUST 10-11-12 JUST 10-11-12 2 meses hace
Got it
👍️0
JUST 10-11-12 JUST 10-11-12 2 meses hace
Why can I not uy Tvgn?
👍️0
knrorrel knrorrel 2 meses hace
SOUNDS AWESOME $TVGN IS READY
👍️0
glenn1919 glenn1919 2 meses hace
TVGN.............................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️0
SolarRevolution SolarRevolution 2 meses hace
Showtime! Momentum , great news, and more news this week!

$$$

:)

Let’s do this !
👍️0
StemCelzRock StemCelzRock 2 meses hace
TVGN heading to $5.00 this week, don’t miss it. Nice PR!!!!!!!! Boom time.
👍️0
knrorrel knrorrel 2 meses hace
looks $TVGN News from Saturday , should moving....💪
🔥🔥🔥🔥🔥 imho
👍️0
dinogreeves dinogreeves 2 meses hace
$5.00 by the end of the week.
👍️0
SolarRevolution SolarRevolution 2 meses hace
The “After, after hours” news release Friday night from the CEO isn’t even priced in yet. Further reinforcing the multi billion, multi year projections and even telling us more news releases within days! This is un precedented, un paralleled and it’s working! The stock price is going up. To me Tevogen’s past two weeks is exactly how the stock market is supposed to work. And I anticipate making $15K here across the next 5 trading days.

Markets are hot right us!

Us longs deserve to make some bank this year!!! GLTA
👍️ 1

Su Consulta Reciente

Delayed Upgrade Clock